Report Overview

The EU Medical Cannabis market size stood at round USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Medical Cannabis is used to treat chronic conditions, such as Cancer, Arthritis, and Neurological disorders, including anxiety, depression, Parkinson's, Epilepsy, and Alzheimer's disease. There have been a dozen mergers and acquisitions or private placements focusing on medical cannabis in Europe. According to the cannabis media, legal marijuana in the medical market creates multiple jobs and opportunities. The prescribed physician categorizes the usage of marijuana; the government controls and regulates marijuana medicine products' distribution. The researchers have revealed that the human body naturally produces its cannabinoids and uses them to regulate homeostasis



Market Drivers

Cannabis is gaining momentum around Europe with the legalization of its product usage. The market is primarily driven by increasing recognition of medical benefits and
therapeutic applications of Marijuana. Marijuana is being used to treat chronic diseases such as cancer and neurological conditions, anxiety, and depression, which is estimated
to increase the market growth. Moreover, marijuana products have been legalized in European countries for medical usage, and it is expected to provide various jobs and opportunities in the developed countries. The legalization of Marijuana has led to an increase in the demand for Marijuana fields the cultivators and manufacturers focus on producing and manufacturing more marijuana products, leading to market growth. Cannabis consumer product companies and retailers are ensuring to meet the needs of the cannabis consumers. Besides, the increasing variety of products, ease of use, product safety, and growing applications of cannabis in various medical conditions are expected to drive the market growth